Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011769
Filing Date
2025-05-02
Accepted
2025-05-02 16:04:53
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05022025_080549.html 4  
1 form4-05022025_080549.xml 4 6180
  Complete submission text file 0001415889-25-011769.txt   7829
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET NEW YORK NY 10013
Business Address
Duncan Barbara Gayle (Reporting) CIK: 0001353128 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 25908388